Ausgabe 3/2025
Inhalt (14 Artikel)
Psychological Health in the Management of Patients with Psoriatic Arthritis: An Intricate Relationship
- Open Access
- Review
Ennio Lubrano, Pasquale Ambrosino, Fabio Massimo Perrotta
Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents
- Open Access
- Review
Anca D. Askanase, Richard Furie, Maria Dall’Era, Andrew S. Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N. Bruce, Munther Khamashta, Bernard Rubin, Angela Carroll, Roger Abramino Levy, Ronald van Vollenhoven, Murray B. Urowitz
The Impact of IL-17A Inhibition in Rheumatic and Musculoskeletal Diseases: Current Insights and Future Prospects
- Open Access
- Review
Sofia Ramiro, Georg Schett, Helena Marzo-Ortega, Wolfgang A. Schmidt
Filgotinib Radiographic and Clinical Efficacy Versus Other JAK Inhibitors and Adalimumab in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Systematic Review and Network Meta-Analysis
- Open Access
- Review
Yoshiya Tanaka, Rene Westhovens, Hong Sun, Carole Van der Donckt, Yan Zhong, Toshihiko Kaise
Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme
- Open Access
- Original Research
Ran Jin, James M. Haughton, Emily J. Goddard, Delphine Courmier, Waldemar Radziszewski, Rachael H. Meadows, James Piercy, Stanley Cohen
Secukinumab Persistence in Patients with Psoriatic Arthritis: An Adalimumab-Matched Retrospective Cohort Database Study (FLYWAY)
- Open Access
- Original Research
Hideto Kameda, Kentaro Ishii, Junna Kiriyama, Toshiaki Mikami, Hideya Uratsuji, Akimichi Morita
High Neutrophil Alkaline Phosphatase Activity in Adult-Onset Still’s Disease
- Open Access
- Original Research
Nana Ding, Haiye Ren, Jialin Teng, Xiaobing Cheng, Junna Ye, Yutong Su, Hui Shi, Qiongyi Hu, Yue Sun, Jianfen Meng, Huihui Chi, Zhuochao Zhou, Jinchao Jia, Chengde Yang, Hong-Lei Liu
A Comparison of the Immunogenicity of Intravenous BAT1806, a Tocilizumab Biosimilar, and Its Reference Product
- Open Access
- Original Research
Hans C. Ebbers, Peter C. Taylor, Xiaomei Leng, Wei Wei, Niamh M. Kinsella, Yinbo Zhou, Xiaolei Yang, Paul Chamberlain
Burden of Glucocorticoid Use and Risk of Toxicities Among Patients with Immunoglobulin-G4-Related Disease: A Retrospective US-Based Claims Study
- Open Access
- Original Research
Zachary S. Wallace, Jenny Y. Park, Elizabeth Serra, Patrick Gagnon-Sanschagrin, Annie Guérin, Kristina Patterson, Haridarshan Patel, Vikesh K. Singh
Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry
- Open Access
- Original Research
Koshiro Sonomoto, Shingo Nakayamada, Hiroaki Tanaka, Atsushi Nagayasu, Yoshiya Tanaka
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis
- Open Access
- Brief Report
Damiano Currado, Onorina Berardicurti, Francesca Saracino, Francesca Trunfio, Lyubomyra Kun, Annalisa Marino, Erika Corberi, Ludovica Lamberti, Piero Ruscitti, Vasiliki Liakouli, Marta Vadacca, Amelia Rigon, Luisa Arcarese, Manuela Pietramale, Francesco De Vincenzo, Marta Vomero, Francesco Ciccia, Roberto Giacomelli, Luca Navarini
A Response to: Letter to the Editor Regarding Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials
- Open Access
- Letter
Grace C. Wright, Eduardo Mysler, Arne Yndestad, Cassandra D. Kinch, Alexis Ogdie
Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
- Open Access
- Correction
Philip J. Mease, Joseph F. Merola, Yoshiya Tanaka, Laure Gossec, Iain B. McInnes, Christopher T. Ritchlin, Robert B. M. Landewé, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates